1. 1018PProgression of disease within 2 years (POD24) is a clinically significant endpoint to identify follicular lymphoma patients with high risk of death. (23rd October 2018) Authors: Sortais, C; Lok, A; Gastinne, T; Mahé, B; Dubruille, V; Blin, N; Howlett, S; Tabah, A; Arnaud, P; Moreau, A; Moreau, P; Leux, C; Le Gouill, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN'S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA. (5th April 2022) Authors: Gay, F; Berdeja, JG; De Stefano, V; Hari, P; Hooper, B; Haltner, A; Kumar, S; Martin, T; Mateos, M-V; Moreau, P; Rosta, E; Samjoo, IA; Usmani, SZ; Weisel, K; Jackson, CC; Olyslager, Y; Schecter, JM; Vogel, M; Garrett, A; Lee, S Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exploring the partonic phase at finite chemical potential within a covariant off-shell transport approach. (October 2020) Authors: Soloveva, E; Moreau, P; Oliva, L; Song, T; Bratkovskaya, E L; Cassing, W Journal: Journal of physics Issue: Volume 1667(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL. (5th April 2022) Authors: Dimopoulos, MA; Oriol, A; Nahi, H; San-Miguel, J; Bahlis, NJ; Usmani, SZ; Rabin, N; Orlowski, RZ; Suzuki, K; Plesner, T; Yoon, SS; Ben Yehuda, D; Richardson, PG; Goldschmidt, H; Reece, D; Ahmadi, T; Qin, X; Garvin Mayo, W; Gai, X; Carey, J Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. (5th April 2022) Authors: Popat, R; Usmani, S; Garfall, A; van de Donk, N; Nahi, H; San-Miguel, J; Oriol, A; Nooka, A; Martin, T; Rosinol, L; Chari, A; Karlin, L; Benboubker, L; Mateos, M; Bahlis, N; Moreau, P; Besemer, B; Martínez-López, J; Sidana, S; Pei, L Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE. (5th April 2022) Authors: Mateos, M; Leleu, X; Zamagni, E; Delforge, M; Bringhen, S; Broijl, A; de la Rubia, J; Shaw, A; Brescianini, A; Gonzalez-McQuire, S; Patel, S; Moreau, P Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell. Issue 4 (July 2017) Authors: Tessoulin, B; Eveillard, M; Lok, A; Chiron, D; Moreau, P; Amiot, M; Moreau-Aubry, A; Le Gouill, S; Pellat-Deceunynck, C Journal: Blood reviews Issue: Volume 31:Issue 4(2017:Jul.) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Plasma physics and control studies planned in JT-60SA for ITER and DEMO operations and risk mitigation. (1st May 2022) Authors: Yoshida, M; Giruzzi, G; Aiba, N; Artaud, J F; Ayllon-Guerola, J; Balbinot, L; Beeke, O; Belonohy, E; Bettini, P; Bin, W; Bierwage, A; Bolzonella, T; Bonotto, M; Boulbe, C; Buermans, J; Chernyshova, M; Coda, S; Coelho, R; Davis, S; Day, C Journal: Plasma physics and controlled fusion Issue: Volume 64:Number 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sustained W-melting experiments on actively cooled ITER-like plasma facing unit in WEST. (8th November 2021) Authors: Corre, Y; Grosjean, A; Gunn, J P; Krieger, K; Ratynskaia, S; Skalli-Fettachi, O; Bourdelle, C; Brezinsek, S; Bruno, V; Chanet, N; Coenen, J; Courtois, X; Dejarnac, R; Delmas, E; Delpech, L; Desgranges, C; Diez, M; Dubus, L; Durif, A; Ekedahl, A Other Names: collab. Journal: Physica scripta Issue: Volume 96:Number 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗